483
Tulex Pharmaceuticals Inc.Tulex Pharmaceuticals Inc. – FDA 483, Mar 24, 2025
Record Details
Tulex Pharmaceuticals Inc. in Cranbury, NJ, a manufacturer of finished drug products, received a Form 483 for significant deficiencies in their quality system. The inspection revealed failures to thoroughly investigate stability failures of finished drug products and inadequate corrective and preventive action procedures. Additionally, the firm lacked scientifically sound laboratory controls and testing procedures for organic impurity analysis.
View Company Profile
ID · a13a486c-928d-431f-847a-5d4f12d53869
Other documents for Tulex Pharmaceuticals Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.